Malignant tumors of the female reproductive system

Safety and Health at Work

Volumn 3, Issue 3, 2012, Pages 166-180

  Weiderpass, Elisabete ^a,b,c,d,e   Labrèche, France ^e  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Public Health Consulting Europe   (Finland)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Endometrial neoplasms; Occupational exposure; Ovarian neoplasms; Uterine cervical neoplasms; Vaginal neoplasms

Indexed keywords

EID: 84875903523     PISSN: 20937911     EISSN: 20937997     Source Type: Journal    
DOI: 10.5491/SHAW.2012.3.3.166     Document Type: Article

References (100)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon (France): International Agency for Research on Cancer. 2010 [cited 2011 Aug 15]. Available from: http://globocan.iarc.fr/.
2. Merritt MA, Cramer DW. Molecular pathogenesis of endometrial and ovarian cancer. Cancer Biomark 2010;9:287-305.
3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, Vol. VIII. IARC Scientific Publication No. 155. Lyon (France): International Agency for Research on Cancer; 2002. 781 p.
4. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24(Suppl 3):S3/11-25.
5. Bosch FX, Cardis E. Cancer incidence correlations: genital, urinary and some tobacco-related cancers. Int J Cancer 1990; 46:178-84.
6. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006;20:207-25.
7. Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003;4:670-8.
8. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP. Preventable exposures associated with human cancers. J Natl Cancer Inst 2011;103:1827-39.
9. Andrae B, Andersson TM, Lambert PC, Kemetli L, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S, Sparén P. Screening and cervical cancer cure: population based cohort study. BMJ 2012;344:e900.
10. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000;13:295-308.
11. Basil JB, Goodfellow PJ, Rader JS, Mutch DG, Herzog TJ. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer 2000;89:1758-64.
12. Faquin WC, Fitzgerald JT, Lin MC, Boynton KA, Muto MG, Mutter GL. Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues. Am J Clin Pathol 2000;113:576-82.
13. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, Powell MA, Hendrickson MR, Kapp DS, Chan JK. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 2006;94:642-6.
14. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982;6:93-108.
15. Eliassen AH, Hankinson SE. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol 2008;630:148-65.
16. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans. Volume 100: A review of human carcinogens. Part E: Personal habits and indoor combustions. Lyon (France): IARC; 2012. p.102-5.
17. World Cancer Research Fund, American Insitute for Cancer Research (AICR). Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007. 517 p.
18. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10:1033-4.
19. McMeekin DS. Sarcoma of the uterus. In: DiSaia PA, Creasman WT, editors. Clinical gynecologic oncology. 7th ed. Philadelphia (PA): Mosby Elsevier; 2007. p. 185-99.
20. McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 2002;12:687-90.
21. Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 2009;54: 355-64.
22. Kokawa K, Nishiyama K, Ikeuchi M, Ihara Y, Akamatsu N, Enomoto T, Ishiko O, Motoyama S, Fujii S, Umesaki N. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003). Int J Gynecol Cancer 2006;16:1358-63.
23. Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Gynecol Oncol 2008;111:74-81.
24. Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, Runowicz CD. Association of tamoxifen and uterine sarcoma. J Clin Oncol 2002;20:2758-60.
25. Arenas M, Rovirosa A, Hernández V, Ordi J, Jorcano S, Mellado B, Biete A. Uterine sarcomas in breast cancer patients treated with tamoxifen. Int J Gynecol Cancer 2006;16:861-5.
26. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004;93:204-8.
27. Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 1986;76:399-402.
28. Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol 2009;472:413-37.
29. Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer 2003; 97(10 Suppl):2631-42.
30. Averette HE, Nguyen H. Gynecologic cancer. In: Murphy GP, Lawrence L Sr, Lenhard RE, editors. American Cancer Society textbook of clinical oncology. 2nd ed. Atlanta (GA): American Cancer Society; 1995. p. 552-79.
31. Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res 2008;658:215-33.
32. Tavassoli FA, Devilee P; International Agency for Research on Cancer (IARC). IARC WHO classification of tumours series, vol. 4. Pathology and genetics of tumours of the breast and female genital organs. Lyon (France): IARC; 2003. 432 p.
33. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284: 878-81.
34. Riska A, Leminen A. Determinants of incidence of primary fallopian tube carcinoma (PFTC). Methods Mol Biol 2009; 472:387-96.
35. Agents classified by the International Agency for Research on Cancer (IARC) Monographs, volumes 1-102 [Internet]. Lyon (France): IARC. 2011 [cited 2011 Aug 15]. Available from: http://monographs.iarc.fr/ENG/Classification/ ClassificationsGroupOrder. pdf/.
36. Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Guha N, Freeman C, Galichet L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-part C: metals, arsenic, dusts, and fibres. Lancet Oncol 2009;10:453-4.
37. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans. Volume 63: Dry cleaning, some chlorinated solvents and other industrial chemicals. Lyon (France): IARC; 1995. 551 p.
38. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans. Volume 75: Ionizing radiation. Part 1: X-and gamma (γ)-radiation, and neutrons. Lyon (France): IARC; 2000. 491 p.
39. National Toxicology Program (NTP). Report on carcinogens. 12th ed. Research Triangle Park (NC): Department of Health and Human Services, Public Health Service, NTP; 2011. 499 p.
40. Kauppinen T, Toikkanen J, Pedersen D, Young R, Ahrens W, Boffetta P, Hansen J, Kromhout H, Maqueda Blasco J, Mirabelli D, de la Orden-Rivera V, Pannett B, Plato N, Savela A, Vincent R, Kogevinas M. Occupational exposure to carcinogens in the European Union. Occup Environ Med 2000;57:10-8.
41. Ruder AM, Ward EM, Brown DP. Cancer mortality in female and male dry-cleaning workers. J Occup Med 1994;36:867-74.
42. Blair A, Stewart PA, Tolbert PE, Grauman D, Moran FX, Vaught J, Rayner J. Cancer and other causes of death among a cohort of dry cleaners. Br J Ind Med 1990;47:162-8.
43. Anttila A, Pukkala E, Sallmén M, Hernberg S, Hemminki K. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med 1995;37:797-806.
44. Blair A, Petralia SA, Stewart PA. Extended mortality followup of a cohort of dry cleaners. Ann Epidemiol 2003;13:50-6.
45. Ruder AM, Ward EM, Brown DP. Mortality in dry-cleaning workers: an update. Am J Ind Med 2001;39:121-32.
46. Travier N, Gridley G, De Roos AJ, Plato N, Moradi T, Boffetta P. Cancer incidence of dry cleaning, laundry and ironing workers in Sweden. Scand J Work Environ Health 2002;28: 341-8.
47. Seldén AI, Ahlborg G Jr. Cancer morbidity in Swedish drycleaners and laundry workers: historically prospective cohort study. Int Arch Occup Environ Health 2011;84:435-43.
48. Savitz DA, Andrews KW, Brinton LA. Occupation and cervical cancer. J Occup Environ Med 1995;37:357-61.
49. Sala M, Dosemeci M, Zahm SH. A death certificate-based study of occupation and mortality from reproductive cancers among women in 24 US states. J Occup Environ Med 1998; 40:632-9.
50. Carpenter L, Roman E. Cancer and occupation in women: identifying associations using routinely collected national data. Environ Health Perspect 1999;107(Suppl 2):299-303.
51. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparén P, Tryggvadottir L, Weiderpass E, Kjaerheim K. Occupation and cancer-follow-up of 15 million people in five Nordic countries. Acta Oncol 2009;48:646-790.
52. Wesseling C, Ahlbom A, Antich D, Rodriguez AC, Castro R. Cancer in banana plantation workers in Costa Rica. Int J Epidemiol 1996;25:1125-31.
53. Settimi L, Comba P, Carrieri P, Boffetta P, Magnani C, Terracini B, Andrion A, Bosia S, Ciapini C, De Santis M, Desideri E, Fedi A, Luccoli L, Maiozzi P, Masina A, Perazzo PL, Axelson O. Cancer risk among female agricultural workers: a multicenter case-control study. Am J Ind Med 1999;36:135-41.
54. Colt JS, Stallones L, Cameron LL, Dosemeci M, Zahm SH. Proportionate mortality among US migrant and seasonal farmworkers in twenty-four states. Am J Ind Med 2001;40: 604-11.
55. Ma F, Fleming LE, Lee DJ, Trapido E, Gerace TA. Cancer incidence in Florida professional firefighters, 1981 to 1999. J Occup Environ Med 2006;48:883-8.
56. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 2007;33:336-43.
57. Weiderpass E, Pukkala E, Vasama-Neuvonen K, Kauppinen T, Vainio H, Paakkulainen H, Boffetta P, Partanen T. Occupational exposures and cancers of the endometrium and cervix uteri in Finland. Am J Ind Med 2001;39:572-80.
58. Boffetta P, Dosemeci M, Gridley G, Bath H, Moradi T, Silverman D. Occupational exposure to diesel engine emissions and risk of cancer in Swedish men and women. Cancer Causes Control 2001;12:365-74.
59. Kuzmickiene I, Didziapetris R, Stukonis M. Cancer incidence in the workers cohort of textile manufacturing factory in Alytus, Lithuania. J Occup Environ Med 2004;46:147-53.
60. Laakkonen A, Verkasalo PK, Nevalainen A, Kauppinen T, Kyyrönen P, Pukkala EI. Moulds, bacteria and cancer among Finns: an occupational cohort study. Occup Environ Med 2008;65:489-93.
61. Petralia SA, Dosemeci M, Adams EE, Zahm SH. Cancer mortality among women employed in health care occupations in 24 U.S. states, 1984-1993. Am J Ind Med 1999;36:159-65.
62. Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 2002;13:625-35.
63. MacArthur AC, Le ND, Abanto ZU, Gallagher RP. Occupational female breast and reproductive cancer mortality in British Columbia, Canada, 1950-94. Occup Med (Lond) 2007; 57:246-53.
64. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res 2007;67:10618-22.
65. John EM, Koo J, Horn-Ross PL. Lifetime physical activity and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2010;19:1276-83.
66. Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E. Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases. Maturitas 2012;72:56-60.
67. Concha-Barrientos M, Nelson DI, Driscoll T, Steenland NK, Punnett L, Fingerhut MA, Prüss-Üstün A, Leigh J, Tak SW, Corvalan C. Selected occupational risk factors. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comaprative quantification of health risks: global and regional burden of diseases attribuatable to selected major risk factors, vol. 1, 2. Geneva (Switzerland): World Health Organization; 2004. p. 1651-802.
68. Toxicological profile for asbestos [Internet]. Atlanta (GA): Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention. 2001 [cited 2011 Aug 15]. Available from: http://www.atsdr.cdc.gov/ toxprofiles/tp.asp?id=30&tid=4
69. Acheson ED, Gardner MJ, Pippard EC, Grime LP. Mortality of two groups of women who manufactured gas masks from chrysotile and crocidolite asbestos: a 40-year follow-up. Br J Ind Med 1982;39:344-8.
70. McDonald JC, Harris JM, Berry G. Sixty years on: the price of assembling military gas masks in 1940. Occup Environ Med 2006;63:852-5.
71. Heller DS, Gordon RE, Westhoff C, Gerber S. Asbestos exposure and ovarian fiber burden. Am J Ind Med 1996;29:435-9.
72. Vasama-Neuvonen K, Pukkala E, Paakkulainen H, Mutanen P, Weiderpass E, Boffetta P, Shen N, Kauppinen T, Vainio H, Partanen T. Ovarian cancer and occupational exposures in Finland. Am J Ind Med 1999;36:83-9.
73. Bulbulyan MA, Ilychova SA, Zahm SH, Astashevsky SV, Zaridze DG. Cancer mortality among women in the Russian printing industry. Am J Ind Med 1999;36:166-71.
74. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Sources and effects of ionizing radiation. UNSCEAR 2008 report to the General Assembly with scientific annexes, vol 1. New York (NY): United Nations; 2010. 20 p.
75. Sigurdson AJ, Doody MM, Rao RS, Freedman DM, Alexander BH, Hauptmann M, Mohan AK, Yoshinaga S, Hill DA, Tarone R, Mabuchi K, Ron E, Linet MS. Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer 2003;97:3080-9.
76. Doody MM, Mandel JS, Lubin JH, Boice JD Jr. Mortality among United States radiologic technologists, 1926-90. Cancer Causes Control 1998;9:67-75.
77. Wang JX, Zhang LA, Li BX, Zhao YC, Wang ZQ, Zhang JY, Aoyama T. Cancer incidence and risk estimation among medical x-ray workers in China, 1950-1995. Health Phys 2002;82:455-66.
78. McGeoghegan D, Binks K. The mortality and cancer morbidity experience of workers at the Springfields uranium production facility, 1946-95. J Radiol Prot 2000;20:111-37.
79. Telle-Lamberton M, Bergot D, Gagneau M, Samson E, Giraud JM, Néron MO, Hubert P. Cancer mortality among French Atomic Energy Commission workers. Am J Ind Med 2004;45:34-44.
80. Ashmore JP, Krewski D, Zielinski JM, Jiang H, Semenciw R, Band PR. First analysis of mortality and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol 1998;148:564-74.
81. Sont WN, Zielinski JM, Ashmore JP, Jiang H, Krewski D, Fair ME, Band PR, Létourneau EG. First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol 2001; 153:309-18.
82. Shields T, Gridley G, Moradi T, Adami J, Plato N, Dosemeci M. Occupational exposures and the risk of ovarian cancer in Sweden. Am J Ind Med 2002;42:200-13.
83. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans. Volume 100: A review of human carcinogens. Part A: Pharmaceuticals. Lyon (France): IARC; 2011. 437 p.
84. Heron RJ, Pickering FC. Health effects of exposure to active pharmaceutical ingredients (APIs). Occup Med (Lond) 2003; 53:357-62.
85. Edling C, Friis L, Mikoczy Z, Hagmar L, Lindfors P. Cancer incidence among pharmaceutical workers. Scand J Work Environ Health 1995;21:116-23.
86. Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health 1994; 20:22-6.
87. Hansen J, Olsen JH, Larsen AI. Cancer morbidity among employees in a Danish pharmaceutical plant. Int J Epidemiol 1994;23:891-8.
88. Guo J, Kauppinen T, Kyyrönen P, Heikkilä P, Lindbohm ML, Pukkala E. Risk of esophageal, ovarian, testicular, kidney and bladder cancers and leukemia among finnish workers exposed to diesel or gasoline engine exhaust. Int J Cancer 2004;111: 286-92.
89. Robinson CF, Walker JT. Cancer mortality among women employed in fast-growing U.S. occupations. Am J Ind Med 1999;36:186-92.
90. Nanni O, Ravaioli A, Bucchi L, Falcini F, Ricci R, Buiatti E, Amadori D. Relative and absolute cancer mortality of women in agriculture in northern Italy. Eur J Cancer Prev 2005;14: 337-44.
91. Koutros S, Alavanja MC, Lubin JH, Sandler DP, Hoppin JA, Lynch CF, Knott C, Blair A, Freeman LE. An update of cancer incidence in the Agricultural Health Study. J Occup Environ Med 2010;52:1098-105.
92. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans. Volume 99: Some aromatic amines, organic dyes and related exposures. Lyon (France): IARC; 2010. 692 p.
93. Takkouche B, Regueira-Méndez C, Montes-Martínez A. Risk of cancer among hairdressers and related workers: a metaanalysis. Int J Epidemiol 2009;38:1512-31.
94. Quach T, Doan-Billing PA, Layefsky M, Nelson D, Nguyen KD, Okahara L, Tran AN, Von Behren J, Reynolds P. Cancer incidence in female cosmetologists and manicurists in California, 1988-2005. Am J Epidemiol 2010;172:691-9.
95. Czene K, Tiikkaja S, Hemminki K. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer 2003;105:108-12.
96. Mabuchi K, Bross DS, Kessler II. Epidemiology of cancer of the vulva. A case-control study. Cancer 1985;55:1843-8.
97. Riska A, Martinsen JI, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Occupation and risk of primary fallopian tube carcinoma in Nordic countries. Int J Cancer 2012;131:186-92.
98. Loukovaara M, Pukkala E, Lehtovirta P, Leminen A. Epidemiology of choriocarcinoma in Finland, 1953 to 1999. Gynecol Oncol 2004;92:252-5.
99. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans. Preamble. Lyon (France): IARC; 2006. 25 p.
100. Toxicological profile for tetrachloroethylene (PERC) [Internet]. Atlanta (GA): Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention. 1997 [cited 2011 Aug 15]. Available from: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=265&tid=48.